Nnamdi Nwachukwu
Nnamdi has global experience in health technology innovation, risk management and market access strategies for a myriad of products including; biologics, vaccines, therapeutics, devices and digital technologies. Experience building quality systems, development operations, providing oversight for product manufacturing, clinical trials and managing cross-functional teams. Proven ability to successfully manage dynamic teams of varying skill levels and geographic locations (4 continents). Additional experience includes leading audits with regulatory agencies and working across disciplines in several technical and clinical areas to ensure programs and systems deliver healthcare interventions and outcomes. Nnamdi is also responsible for the Life Sciences portfolio at the Oxford Angel Fund.
Nnamdi has held several executive and management positions in large and start-up biotech companies. He has managed the vaccines and anti-infectives portfolio at the US Department of Defense. He also spent 3 years with PATH working in conjunction with the Gates Foundation, WHO and Institut Pasteur. Nnamdi has completed a Master's in Evidence-based Medicine from Oxford University, a Master's in Regulatory Affairs in Pharmaceuticals, Biologics and Medical Devices from Northeastern University and a Masters of Healthcare Delivery Science from the Tuck School of Business at Dartmouth College. He has held a certification in Global Regulatory Affairs since 2013 from the Regulatory Affairs Professional Society and is a Fellow of Royal Society of Public Health in the United Kingdom.